CSF3 and Stroke: Immunohistochemistry revealed EPC activation and localization and enhanced vascularization in G-CSF-treated animals, as demonstrated by increased levels of EPC and vasculogenesis markers, CD34+ and VEGFR-2 and vWF, respectively, in the ipsilateral cortex and striatum of stroke animals.